Cooperation is permanent exchanges with research institutions and universities a current project with research and teaching. Gerresheimer supports the College Amberg-Weiden in establishing and operating a research clean room of ISO class 7. This means that not more than 352.000 particles which are larger than 0.5 microns, may reside in one cubic metre of air (normal room air contains a thousand times as many particles). The clean room is two parties: the College to a practical training to ensure and Gerresheimer, counter to control the shortage. We need speak competent engineers, who are specially trained for our needs and the medical jargon of our customers”, explains the company’s commitment Baumann. In the newly constructed Cleanroom should knowledge of the particle – and low-germ production of pharmaceutical Products can be obtained. Regensburg location: the commercial headquarters in Regensburg, Germany the business headquarters of the business field is medical plastic systems of Gerresheimer. The management and controlling/finance and the Legal Department sit here.
The world group Gerresheimer took over the wild group in 2007, which is part of systems today Gerresheimer Regensburg GmbH and as a division of medical plastic the plastic Systems Division. e of information. Site Pfreimd: the production work seven days a week around the clock be plastic systems high automated on the third upper Palatine site Pfreimd produced. The plant has about 12,000 square feet of manufacturing space, of which 8,000 square meters of clean room, as well as 22 fully automated assembly lines. In the Pfreimd, starting the entire production takes place worldwide. The establishment has its own tool service and highly qualified personnel. In March of this year a new pharmaceutical packaging – and filling area was built here. Gerresheimer international Gerresheimer is one of the World’s leading manufacturers of high-quality specialty products made of glass and plastic for the pharmaceutical and health care industries. The product range stretches from medicinal bottles syringe systems, insulin pens and inhalers. The group generated a turnover of about one billion euros at 47 locations in Europe, North and South America and Asia and employs approximately 11,000 people.